These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1007 related articles for article (PubMed ID: 33342543)

  • 1. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
    Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
    Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH.
    Ramadori P; Drescher H; Erschfeld S; Fragoulis A; Kensler TW; Wruck CJ; Cubero FJ; Trautwein C; Streetz KL; Kroy DC
    Oxid Med Cell Longev; 2017; 2017():3420286. PubMed ID: 28676836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
    Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
    J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of Anti-Oxidative Stress Response Improves Metabolic Changes in L-Selectin-Deficient Mice but Does Not Prevent NAFLD Progression or Fecal Microbiota Shifts.
    Eswaran S; Babbar A; Drescher HK; Hitch TCA; Clavel T; Muschaweck M; Ritz T; Kroy DC; Trautwein C; Wagner N; Schippers A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2.
    Bathish B; Robertson H; Dillon JF; Dinkova-Kostova AT; Hayes JD
    Free Radic Biol Med; 2022 Aug; 188():221-261. PubMed ID: 35728768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
    Beraza N; Ofner-Ziegenfuss L; Ehedego H; Boekschoten M; Bischoff SC; Mueller M; Trauner M; Trautwein C
    Gut; 2011 Mar; 60(3):387-96. PubMed ID: 21115542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease.
    To K; Okada K; Watahiki T; Suzuki H; Tsuchiya K; Tokushige K; Yamamoto M; Ariizumi SI; Shoda J
    Cancer Med; 2023 Oct; 12(19):19423-19437. PubMed ID: 37732511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice.
    Lee LY; Köhler UA; Zhang L; Roenneburg D; Werner S; Johnson JA; Foley DP
    Toxicol Sci; 2014 Dec; 142(2):361-74. PubMed ID: 25294219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.
    Okada K; Warabi E; Sugimoto H; Horie M; Tokushige K; Ueda T; Harada N; Taguchi K; Hashimoto E; Itoh K; Ishii T; Utsunomiya H; Yamamoto M; Shoda J
    J Gastroenterol; 2012 Aug; 47(8):924-35. PubMed ID: 22367278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway.
    Zhao S; Song T; Gu Y; Zhang Y; Cao S; Miao Q; Zhang X; Chen H; Gao Y; Zhang L; Han Y; Wang H; Pu J; Xie L; Ji Y
    Hepatology; 2021 Jan; 73(1):282-302. PubMed ID: 32219872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
    Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
    Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
    Tocmo R; Parkin K
    Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatotic Hepatocytes Release Mature VLDL Through Methionine and Tyrosine Metabolism in a Keap1-Nrf2-Dependent Manner.
    Sano A; Kakazu E; Hamada S; Inoue J; Ninomiya M; Iwata T; Tsuruoka M; Sato K; Masamune A
    Hepatology; 2021 Sep; 74(3):1271-1286. PubMed ID: 33724516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
    Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB essential modifier is required for hepatocyte proliferation and the oval cell reaction after partial hepatectomy in mice.
    Malato Y; Ehedego H; Al-Masaoudi M; Cubero FJ; Bornemann J; Gassler N; Liedtke C; Beraza N; Trautwein C
    Gastroenterology; 2012 Dec; 143(6):1597-1608.e11. PubMed ID: 22922425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis.
    Ehedego H; Boekschoten MV; Hu W; Doler C; Haybaeck J; Gaβler N; Müller M; Liedtke C; Trautwein C
    Cancer Res; 2015 Mar; 75(6):1144-55. PubMed ID: 25608711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.
    Lee DH; Park JS; Lee YS; Han J; Lee DK; Kwon SW; Han DH; Lee YH; Bae SH
    Autophagy; 2020 Nov; 16(11):1949-1973. PubMed ID: 31913745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis.
    Wasik U; Milkiewicz M; Kempinska-Podhorodecka A; Milkiewicz P
    Sci Rep; 2017 Mar; 7():44769. PubMed ID: 28333129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.